pMSCV-IRES-CFP II (pMIC II) Citations (3)

Originally described in: Generation of T-cell receptor retrogenic mice.
Holst J, Szymczak-Workman AL, Vignali KM, Burton AR, Workman CJ, Vignali DA Nat Protoc. 2006;1(1):406-17. PubMed Journal

---

Articles Citing pMSCV-IRES-CFP II (pMIC II)

Articles
BCL6 corepressor contributes to Th17 cell formation by inhibiting Th17 fate suppressors. Kotov JA, Kotov DI, Linehan JL, Bardwell VJ, Gearhart MD, Jenkins MK. J Exp Med. 2019 Jun 3;216(6):1450-1464. doi: 10.1084/jem.20182376. Epub 2019 May 3. PubMed
Metoclopramide treatment blocks CD93-signaling-mediated self-renewal of chronic myeloid leukemia stem cells. Riether C, Radpour R, Kallen NM, Burgin DT, Bachmann C, Schurch CM, Luthi U, Arambasic M, Hoppe S, Albers CE, Baerlocher GM, Ochsenbein AF. Cell Rep. 2021 Jan 26;34(4):108663. doi: 10.1016/j.celrep.2020.108663. PubMed
p16(INK4a) Regulates Cellular Senescence in PD-1-Expressing Human T Cells. Janelle V, Neault M, Lebel ME, De Sousa DM, Boulet S, Durrieu L, Carli C, Muzac C, Lemieux S, Labrecque N, Melichar HJ, Mallette FA, Delisle JS. Front Immunol. 2021 Aug 9;12:698565. doi: 10.3389/fimmu.2021.698565. eCollection 2021. PubMed

If you have published an article using this material, please email us at to have your article added to this page.